Scott Shelfo, MD
Urology · Newnan, GANPI 1053414458
Payments from drug & device makers
Across 88 payments — averaging $59.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Boston Scientific$404
- Novartis$247
- Astellas Pharma US Inc$215
- Johnson & Johnson$159
- Teleflex LLC$149
- plus $882 from 19 others
What the payments were for
- Speaking & faculty fees$3,00057%
- Food & beverage$1,96738%
- Education$2535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $3,164 |
| Boston Scientific | 6 | $404 |
| Novartis | 14 | $247 |
| Astellas Pharma US Inc | 10 | $215 |
| Johnson & Johnson(2 entities) | 6 | $159 |
| Teleflex LLC | 2 | $149 |
| Amgen | 5 | $94 |
| Merck | 6 | $94 |
| Angiodynamics, Inc. | 4 | $93 |
| Seagen Inc. | 1 | $80 |
| Rochester Medical Corporation | 5 | $67 |
| Bayer | 4 | $65 |
| Ambu Inc. | 1 | $51 |
| Immunitybio, Inc. | 2 | $47 |
| AstraZeneca | 3 | $44 |
| Bristol Myers Squibb | 3 | $43 |
| Eisai Inc. | 2 | $43 |
| Urogen Pharma, Inc. | 1 | $33 |
| Axonics, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
| Array Biopharma Inc | 1 | $19 |
| Koelis Inc. | 1 | $17 |
| Sanofi | 1 | $13 |
| Exelixis Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,000
- UroLift$125
- AMS 700$106
How this compares
$5,220 in reported general payments places this provider in the 50th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 30 | $376 |
| Oxycodone Hcl | 44 | $152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $135 |
| Ciprofloxacin Hcl | 45 | $131 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $123 |
| Cephalexin | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other urology in Newnan
- Micah BlackmonNewnan$15K
- Vahan KassabianRoswell$3M
- Viraj MasterAtlanta$2M
- Vikram NarayanAtlanta$1.1M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$611K
- Kenneth OganAtlanta$425K
- Jason LomboyMarietta$280K
- Syed JafriDecatur$177K
- Jeffrey ProctorCartersville$167K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.